Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6272 | 1441 | 30.3 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2282 | 4190 | INTERSTITIAL CYSTITIS//CYSTITIS INTERSTITIAL//PAINFUL BLADDER SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IFOSFAMIDE | Author keyword | 97 | 30% | 19% | 274 |
2 | TROFOSFAMIDE | Author keyword | 43 | 79% | 2% | 27 |
3 | BNP7787 | Author keyword | 42 | 94% | 1% | 15 |
4 | MESNA | Author keyword | 27 | 39% | 4% | 56 |
5 | GLUFOSFAMIDE | Author keyword | 24 | 82% | 1% | 14 |
6 | ISOPHOSPHORAMIDE MUSTARD | Author keyword | 24 | 91% | 1% | 10 |
7 | CHLOROACETALDEHYDE | Author keyword | 21 | 52% | 2% | 29 |
8 | OXAZAPHOSPHORINE | Author keyword | 21 | 75% | 1% | 15 |
9 | DIMESNA | Author keyword | 11 | 100% | 0% | 6 |
10 | 4 HYDROXYCYCLOPHOSPHAMIDE | Author keyword | 10 | 63% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IFOSFAMIDE | 97 | 30% | 19% | 274 | Search IFOSFAMIDE | Search IFOSFAMIDE |
2 | TROFOSFAMIDE | 43 | 79% | 2% | 27 | Search TROFOSFAMIDE | Search TROFOSFAMIDE |
3 | BNP7787 | 42 | 94% | 1% | 15 | Search BNP7787 | Search BNP7787 |
4 | MESNA | 27 | 39% | 4% | 56 | Search MESNA | Search MESNA |
5 | GLUFOSFAMIDE | 24 | 82% | 1% | 14 | Search GLUFOSFAMIDE | Search GLUFOSFAMIDE |
6 | ISOPHOSPHORAMIDE MUSTARD | 24 | 91% | 1% | 10 | Search ISOPHOSPHORAMIDE+MUSTARD | Search ISOPHOSPHORAMIDE+MUSTARD |
7 | CHLOROACETALDEHYDE | 21 | 52% | 2% | 29 | Search CHLOROACETALDEHYDE | Search CHLOROACETALDEHYDE |
8 | OXAZAPHOSPHORINE | 21 | 75% | 1% | 15 | Search OXAZAPHOSPHORINE | Search OXAZAPHOSPHORINE |
9 | DIMESNA | 11 | 100% | 0% | 6 | Search DIMESNA | Search DIMESNA |
10 | 4 HYDROXYCYCLOPHOSPHAMIDE | 10 | 63% | 1% | 10 | Search 4+HYDROXYCYCLOPHOSPHAMIDE | Search 4+HYDROXYCYCLOPHOSPHAMIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 4 HYDROXYCYCLOPHOSPHAMIDE | 72 | 83% | 3% | 40 |
2 | N DECHLOROETHYLATION | 64 | 79% | 3% | 41 |
3 | OXAZAPHOSPHORINES | 59 | 65% | 4% | 56 |
4 | ISOPHOSPHAMIDE NSC 109724 | 55 | 87% | 2% | 27 |
5 | MESNA | 54 | 33% | 9% | 134 |
6 | ISOPHOSPHORAMIDE MUSTARD | 45 | 90% | 1% | 19 |
7 | ACTIVATED CYCLOPHOSPHAMIDE | 42 | 94% | 1% | 15 |
8 | DIMESNA | 41 | 100% | 1% | 15 |
9 | IFOSFAMIDE ACTIVATION | 38 | 70% | 2% | 31 |
10 | PHOSPHORAMIDE MUSTARD | 37 | 45% | 4% | 62 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Clinical pharmacokinetics of cyclophosphamide | 2005 | 102 | 162 | 62% |
Metabolism and pharmacokinetics of oxazaphosphorines | 2000 | 99 | 108 | 69% |
Nephrotoxicity-What Do We Know and What Don't We Know? | 2011 | 16 | 81 | 53% |
Oxazaphosphorines: new therapeutic strategies for an old class of drugs | 2010 | 20 | 132 | 77% |
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites | 2001 | 58 | 162 | 85% |
IFOSFAMIDE, MESNA, AND NEPHROTOXICITY IN CHILDREN | 1993 | 166 | 90 | 72% |
Cyclophosphamide and related anticancer drugs | 2001 | 51 | 127 | 74% |
The chemistry of the metabolites of cyclophosphamide | 1999 | 83 | 47 | 77% |
CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE | 1991 | 195 | 53 | 51% |
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention | 2009 | 14 | 87 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KRIGO | 4 | 75% | 0.2% | 3 |
2 | NIOMECH | 3 | 100% | 0.2% | 3 |
3 | CIHR GSK CHAIR PAEDIAT CLIN PHARMACOL | 3 | 50% | 0.3% | 4 |
4 | METAB MALAD METAB U820 | 2 | 67% | 0.1% | 2 |
5 | CLIN PHARMACOL TOXICOL PHARMACOKINET | 1 | 100% | 0.1% | 2 |
6 | EWING SARCOMA TRIAL | 1 | 100% | 0.1% | 2 |
7 | LESS | 1 | 29% | 0.3% | 4 |
8 | SECT DRUG TOXICOL | 1 | 20% | 0.3% | 5 |
9 | EA 3535 | 1 | 40% | 0.1% | 2 |
10 | CHEM TECHNOL PHARMACEUT | 1 | 21% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000244048 | UROTOXICITY//HEMORRHAGIC CYSTITIS//PECAN NUT SHELLS |
2 | 0.0000214406 | N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA |
3 | 0.0000119253 | TRABECTEDIN//ET 743//YONDELIS |
4 | 0.0000084312 | PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS |
5 | 0.0000055229 | NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY |
6 | 0.0000054577 | INTRATHECAL VINCRISTINE//METHYLTHIONINIUM CHLORIDE//METABOLIC ENHANCER |
7 | 0.0000049347 | 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS |
8 | 0.0000048171 | 1 3 2 DIOXAPHOSPHORINANE//DIORGANODICHLOROSILANES//ORGANOPHOSPHORUS HETEROCYCLES |
9 | 0.0000045260 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
10 | 0.0000044038 | ANTINEOPLASTIC DRUGS//TOXICITY ENVIRONMENTAL//HAZARDOUS DRUGS |